Biogen Files With FDA for Approval of Alzheimer’s Therapy

(Bloomberg) -- Biogen Inc. said it had submitted an application seeking U.S. clearance for its controversial Alzheimer’s disease therapy aducanumab, which if approved would be the first medicine av...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.